| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.004 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |